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With the goal in mind to define how interleukin-15
(IL-15) contributes to acute intestinal inflammation,
we have used a mouse model of ileitis induced by
oral infection with Toxoplasma gondii. We observed
that a crosstalk between IL-15 and interleukin-18
(IL-18) promoted intestinal recruitment of inflamma-
tory monocytes, where these cells participated in
parasite control but also in tissue damage. A stromal
source of IL-15 controlled the development of lamina
propria NKp46+NK1.1+ cells, whereas IL-18 pro-
duced during T. gondii infection stimulated their
production of the chemokine CCL3. In turn, CCL3
attracted inflammatory monocytes via their chemo-
kine receptor CCR1, which was indispensable for
their recruitment into the inflamed gut. Collectively,
these results identify the IL-15-dependent subset of
intestinal NKp46+ cells as an important source of
CCL3, which can amplify intestinal inflammation via
the recruitment of CCR1+ inflammatory monocytes.
Preliminary evidence suggests that this pathway
might operate in Crohn’s disease.
INTRODUCTION
Interleukin 15 (IL-15) is a pleiotropic cytokine with a large range
of functions at the interface between innate and adaptive immu-
nity. An essential role in the differentiation, survival, and/or
activation of natural killer (NK), NKT cells, gd T cell receptor+
(TCR) intraepithelial lymphocytes (IELs), and CD8+ memory
T cells is firmly established in mice lacking IL-15 or IL-15
receptor a chain (IL-15Ra) (Kennedy et al., 2000; Lodolce108 Immunity 37, 108–121, July 27, 2012 ª2012 Elsevier Inc.et al., 1998) or, conversely, overexpressing IL-15 (Fehniger
et al., 2001; Ohta et al., 2002). In humans, IL-15 is thought to
participate in the pathogenesis of a spectrum of inflammatory
or autoimmune diseases. In rheumatoid arthritis, increased
IL-15 concentrations are found in the synovium, and IL-15 is
suggested to exert direct chemoattractant activity toward syno-
vial T cells to stimulate their proliferation and their production of
tumor necrosis factor-a (TNF-a). IL-15-activated T cells can also
stimulate TNF-a production by peripheral blood monocytes
and tissue macrophages via a contact-dependent mechanism
(McInnes et al., 1996, 1997). A similar mechanism has been
suggested in Crohn’s disease (CD) (Liu et al., 2000). In CD,
increased numbers of IL-15-producing mononuclear cells are
observed in the intestinal lamina propria (LP), and augmented
serum concentrations of IL-15 are found to predict patients’
response to anti-TNF-a treatment (Bouchaud et al., 2010). Alter-
natively, we and others have suggested that in celiac disease,
chronic overexpression of IL-15 by intestinal epithelial cells
drives the expansion and activation of cytotoxic CD8+abTCR+
IELs that may destroy epithelial cells via an NK-like mechanism
involving the NKG2D receptor (Hu¨e et al., 2004; Meresse et al.,
2004). This mechanism has also been invoked to explain epithe-
lial destruction in a mouse model of acute intestinal inflamma-
tion induced by intraperitoneal injection of poly(I:C) (Zhou
et al., 2007). Finally, other studies suggest that IL-15 might
impair immunoregulatory mechanisms and thereby promote
CD8+ and CD4+ T cell effector responses (Ben Ahmed et al.,
2009; Benahmed et al., 2007; DePaolo et al., 2011; Hmida
et al., 2012).
To delineate the role of IL-15 in intestinal inflammation, we
have used a mouse model of acute ileitis induced by oral infec-
tion of C57BL/6 mice with Toxoplasma gondii. In this strain of
mice, the intestinal immune reaction is necessary to eliminate
the parasite but is excessive and results in lethal jejuno-ileitis.
Intestinal inflammation depends on the activation of CD4+ T
helper 1 (Th1) intestinal LP cells specific for the triggering antigen
Figure 1. IL-15 Controls T. gondii-Induced Intestinal Inflammation
(A and E) Comparison of survival curves after oral infection by T. gondii in Il15/ versusWTmice (A) and in irradiatedWT or Il15/mice reconstituted with Il15/
or WT bone marrow (BM) (E).
(B) Representative sections of paraffin-embedded jejunum stained with hematoxylin-eosin in WT and Il15/ at day 7 p.i.
(C and D) Parasite load per 30 mg tissue as quantified by qRT-PCR on day 7 p.i. in gut (C) and MLN (D) from Il15/, WT, and Ifng/ mice.
*p < 0.05; **p < 0.005; ***p < 0.0005. See also Figure S1.
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NK Cell-Dependent Recruitment of Gut Monocytes(Liesenfeld et al., 1996; Rachinel et al., 2004), but several
complementary mechanisms are believed to participate in both
pathogen exclusion and inflammation, notably the activation of
CD8+abTCR+ IELs (Charde`s et al., 1994; Egan et al., 2009) and
that of inflammatory monocytes (Dunay et al., 2008). Further-
more, a prior report with Il15/ mice has suggested that IL-15
may be necessary for both protection and inflammation during
T. gondii infection (Combe et al., 2006).
We have shown herein that IL-15, although not required to
control parasite replication, is necessary for the development
of inflammation and tissue destruction. The proinflammatory
effect of IL-15 did not depend on IEL activation and IL-15 was
dispensable for the development of the CD4+ Th1 cell response.
In contrast, IL-15 amplified the recruitment of CCR1+ inflamma-
tory monocytes. We have shown that a nonhematopoietic
source of IL-15 controlled the development and function of
a subset of intestinal NKp46+ innate lymphoid cells that pro-
duced CCL3 in response to inflammatory cytokines, and notably
to IL-18 during T. gondii infection. In turn, CCL3 attracted CCR1+
inflammatory monocytes via the CCR1 receptor, which was
indispensable for the recruitment of the latter cells toward the
inflamed gut. Preliminary evidence suggests that this pathway
may operate in CD.RESULTS
IL-15 Promotes the Severity of Intestinal Inflammation
Induced by T. gondii in C57BL/6 Mice
In wild-type male C57BL/6 mice, oral gavage with 35 cysts of
T. gondii strain 76K induced a severe jejuno-ileitis leading rapidly
to death (Figure 1A). In Il15/ mice, oral infection induced
weight loss (Figure S1A available online), but all animals survived
the early phase of infection and the severity of intestinal lesions
was markedly attenuated (Figure 1B). In contrast, no increase
in parasite load was observed in the intestine, mesenteric lymph
nodes (MLNs) (Figures 1C and 1D), liver, or spleen of Il15/mice
(Figures S1C and S1D) and the majority of Il15/mice were still
alive at 40 days postinfection (p.i.) (Figure S1B), indicating that
IL-15 is redundant to control parasite replication but contributes
to intestinal inflammation in this model. These results differen-
tiate the role of IL-15 from that of interferon-g (IFN-g), which is
necessary not only to induce intestinal inflammation (Liesenfeld
et al., 1996) but also to control local and systemic replication
of the parasite (Figures 1C and 1D). IL-15 can be produced by
many cell types, including enterocytes, dendritic cells (DCs),
and macrophages. Accordingly, upregulation of IL-15 mRNA
after T. gondii infection was observed in enterocytes as well asImmunity 37, 108–121, July 27, 2012 ª2012 Elsevier Inc. 109
Figure 2. The Enhancing Role of IL-15 in T. gondii-Induced Intestinal Inflammation Depends neither on IELs nor on CD4+ Th1 Cells
(A) Comparison of IEL subsets in WT and Il15/ mice and in Il15/ and WT chimeras reconstituted with BM from WT and Il15/ mice, respectively.
(B–D) Survival curves of T. gondii-infected Tcrd/ (B), Prf1/ (C), and B2m/ (D) mice compared to WT mice.
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NK Cell-Dependent Recruitment of Gut Monocytesin CD11c+CD11b+/ DCs isolated from LP and MLN (Figures
S1E–S1G). To determine which source of IL-15 controls the
severity of the ileitis, the outcome of T. gondii infection was
compared in hematopoietic chimeras. As shown in Figure 1E,
all irradiated WT mice reconstituted with Il15/ bone marrow
(BM) developed a lethal ileitis whereas 80% of Il15/ mice re-
constituted with WT BM survived (p < 0.005), indicating that
a nonhematopoietic source of IL-15, presumably epithelial cells,
controls the intensity of intestinal inflammation.
IELs Are Not Central to the Enhancing Effect of IL-15 on
Intestinal Inflammation during T. gondii-Induced Ileitis
A stromal source of IL-15 is necessary for the expansion of
CD8aa+ IELs and more particularly of gdTCR+ IELs (Schluns
et al., 2004). Accordingly, gdTCR+ IELs were almost absent in
Il15/ mice reconstituted or not with WT BM, which developed
an attenuated form of ileitis (Figure 2A). Adoptive transfer of 5 3
106 gdTCR+ IELs did not aggravate the course of the ileitis in
Il15/ recipients (Figure S2A) and, in keeping with previous
observations (Liesenfeld et al., 1996), Tcrd/ mice developed
a lethal ileitis (Figure 2B). Therefore, it is unlikely that gdTCR+
IELs contributed to IL-15-driven inflammation.
Nonhematopoietic cell-derived IL-15 might also activate cyto-
toxic CD8+abTCR+ IELs. After oral infection with T. gondii, this
subset of IELs can kill T. gondii-infected targets in vitro (Charde`s
et al., 1994). In addition, IL-15 can stimulate IEL cytotoxicity by
inducing perforin and granzymes (Mention et al., 2003) or by
enhancing expression of and/or signaling via the activating
NKG2D receptor (Hu¨e et al., 2003; Meresse et al., 2004). We
found that NKG2D expression increased significantly in LP
CD8+abTCR+ lymphocytes from WT but not Il15/ mice (Fig-
ure S2B) but IELs remained largely NKG2D negative during
T. gondii ileitis (data not shown) and administration of a blocking
NKG2D antibody (Ogasawara et al., 2004) did not modify the
course of the disease in WT mice (Figure S2C). Finally, neither
the course of the ileitis (Figures 2C and 2D) nor the parasitic
load (data not shown) were modified in either Prf1/ or
B2m/ mice, arguing against a major contribution of cytotoxic
CD8+ T cells to early protection against the parasite. These
results also point to a need for IL-15-mediated amplification of
intestinal inflammation in this acute model.
IL-15 Is Dispensable for the Induction of T. gondii-
Specific Th1 Cell Responses
A previous study suggested that IL-15 promotes a specific Th1
cell response during T. gondii infection (Combe et al., 2006).
This response is thought to be initiated by infected mucosal
CD11c+ DCs, which migrate to MLNs between days 3 and 7 p.i.
(Courret et al., 2006) and elicit specific CD4+ Th1 cells that
home to the LP. IFN-gmRNA and protein expression were there-
fore compared on days 0, 3, 5, and 7 in jejunal biopsies (Figures
S2D and S2E) and in cells isolated from MLN and LP of Il15/
and WT mice (Figures 2E and 2F, left). Upregulation of IFN-g(E and F) Synthesis of IFN-g by MLN (E) and LPL (F) from naive and infected Il1
percentages of isolated CD4+ T cells spontaneously expressing intracellular IFN
(G and H) IFN-g secretion evaluated by ELISA after a 72 hr culture with (+) or
lymphocytes isolated from MLN (G) or LP (H) in naive (N) and infected Il15/ an
NS, not significant; *p < 0.05; **p < 0.005; ***p < 0.0005. See also Figure S2.mRNA was slightly delayed in MLN lymphocytes of Il15/ mice
and a small amount of IFN-g secretion was induced by soluble
T. gondii antigen (STAg) from LPL in WT but not Il15/ mice on
day 5 (Figures 2E and 2G). Yet, on day 7, LPL from both groups
of animals spontaneously produced massive and comparable
amounts of IFN-g, which did not further increase in the presence
of STAg (Figure 2H). Furthermore, no difference could be demon-
strated between WT and Il15/ mice in the percentages of
IFN-g-producing CD4+ T cells in either the MLN or LPL at all
time points (Figures 2E and 2F, right). Finally, no difference
could be demonstrated in the percentage of CD4+CD25+Foxp3+
T cells in the LP of WT and Il15/mice on days 5 and 7 p.i. (Fig-
ure S2F). Altogether, these results indicate that WT and Il15/
mice develop comparable CD4+ Th1 cell responses, a finding in
keepingwith comparable parasitic burden in both animal groups.Recruitment of Inflammatory Monocytes Is Impaired in
Il15–/– Mice during T. gondii-Induced Ileitis
Inflammation in WT and Il15/ mice was next assessed by
comparing intestinal IL-1b, TNF-a, and IL-6 production during
infection. Upregulation of IL-1b, TNF-a, and IL-6 mRNA was first
observed in intestinal biopsies and in isolated LP cells on day 5
p.i. and increased markedly on day 7 when copious amounts
of IL-1b, TNF-a, and IL-6 were spontaneously released in the
supernatants of biopsies (Figures S3A and S3B) or isolated LP
(Figures 3A and S3C). Upregulation of inflammatory cytokines
was observed in all mice but was significantly higher in WT
than in Il15/ mice.
To identify the cellular source of inflammatory cytokines, LP
cells were isolated from infected WT mice on day 7 and sorted
into CD3+, CD19+, CD3NK1.1+, or CD45+CD3CD19NK1.1
cells. Reverse transcriptase-polymerase chain reaction (RT-
PCR) and ELISA analysis showed that IL-1b, TNF-a, and IL-6
mRNA and IL-1b and TNF-a secretion were upregulated only
in CD45+CD3CD19NK1.1 LP cells (Figures 3B and S3D).
The latter subset was further separated into neutrophils
(Ly6G+Ly6C+CD11b+), inflammatory monocytes (Ly6ChiF4/
80+Ly6GCD11b+CD11c), and resident macrophages (F4/80+
CD11b+Ly6CLy6G) and their secretion tested by ELISA.
Inflammatory monocytes released conspicuous amounts of
IL-1b, TNF-a, and IL-6 whereas much smaller amounts of
TNF-a and IL-6 were produced by neutrophils and macro-
phages, respectively (Figure S3E). Flow cytometry analysis
confirmed that inflammatory monocytes were the main pro-
ducers of TNF-a (Figure 3C). These data suggested that IL-15
was necessary to promote the activation and/or the recruitment
of inflammatory monocytes. IL-15 did not induce the production
of TNF-a and/or IL-1b in peritoneal macrophages from WT mice
(naive or infected with T. gondii) (not shown). IL-15 also failed
to stimulate the production of inflammatory cytokines by LP
cells from naive WT mice even after stimulation by LPS or CD3
and CD28 antibodies (Figures S3F–3H). In contrast, the percent-
ages as well as the absolute numbers of inflammatory5/ and WT mice. Left: qRT-PCR quantification of IFN-g transcripts. Right:
-g.
without () 15 mg/ml of soluble T. gondii antigen (STAg) in supernatants of
d WT mice.
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Figure 3. The Recruitment of Inflammatory Monocytes Is Impaired in Il15–/– Mice during T. gondii-Induced Ileitis
(A) Spontaneous secretion of IL-1b, TNF-a, and IL-6 evaluated by ELISA in 72 hr culture supernatants of LP cells from Il15/ and WT mice either naive or on
day 7 p.i.
(B) qRT-PCR quantification of IL-1b, TNF-a, and IL-6 transcripts in flow cytometry-sorted CD45+ LP B (CD19+), NK (CD3NK1.1+), and T (CD3+) cells and in the
negative CD45+CD3CD19NK1.1 LP cells (neg) on day 7 p.i. in Il15/ and WT mice. Results from one experiment with a pool of ten mice.
(C) Surface phenotype of LP cells containing intracellular TNF-a on day 7 p.i. in WT mice: one representative out of five experiments.
(D) Percentages and absolute numbers of LP Ly6ChiF4/80+ inflammatory monocytes in WT mice on days 3, 5, and 7 p.i.
(E) Percentages of LP Ly6ChiF4/80+CCR1+ inflammatory monocytes in Il15/ and WT mice on days 5 and 7 p.i.
NS, not significant; *p < 0.05; **p < 0.005; ***p < 0.0005. See also Figure S3.
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NK Cell-Dependent Recruitment of Gut Monocytesmonocytes, which increased on day 5 and even more on day 7
p.i. in infected WT mice (Figure 3D), were significantly reduced
in Il15/ mice, suggesting that IL-15 stimulates the recruitment
of inflammatory monocytes (Figure 3E and data not shown).
IL-15 Promotes CCR1- and CCL3-Dependent
Recruitment of Inflammatory Monocytes during
T. gondii-Induced Ileitis
One attractive hypothesis to explain the role of IL-15 was the
induction of chemokines able to stimulate intestinal migration of112 Immunity 37, 108–121, July 27, 2012 ª2012 Elsevier Inc.inflammatory monocytes. mRNA for such chemokines including
CCL2, CCL3, CCL4, CCL5, and CXCL10 were markedly
increased in intestinal biopsies and in isolated LP cells on day
7 p.i. compared to naive animals. The increase was comparable
in WT and Il15/ mice except for CCL3 mRNA, which
were less induced in Il15/ mice (Figures 4A, 4B, and S4A–
S4C). Accordingly, CCL3 concentrations were significantly
reduced in supernatants of LP cells from infected Il15/mice
(Figure 4C). Confirming a role of CCL3 in inflammatory mono-
cytes recruitment, treatment with a blocking CCL3 antibody
Immunity
NK Cell-Dependent Recruitment of Gut Monocytessignificantly reduced the percentage of Ly6ChiF4/80+ LP cells
(Figure 4D) and the production of TNF-a (Figure 4E). Anti-CCL3
treatment also reduced the severity of histological lesions (Fig-
ure 4F) but did not affect overall survival (Figure 4G).
CCL3 binds two distinct receptors, CCR1 and CCR5, both of
which can be expressed by inflammatory monocytes. On day 7
p.i., CCR5 mRNA were similarly increased in jejunal biopsies
and in LP cells from WT and Il15/ mice. In contrast, CCR1
mRNA was significantly lower in Il15/ than in WT mice (Fig-
ure 4H). The role of CCR1 in the recruitment of inflammatory
monocytes was therefore assessed with Ccr1/ mice. Con-
trasting with their recruitment in infected WT mice, no increase
in Ly6ChiF4/80+ LP cells nor in TNF-a+CD45+ LP cells was
observed in Ccr1/ mice during T. gondii infection and the
percentage of such cells on day 7 were even lower than in
Il15/ mice (Figures 4I and 4J). Accordingly, IL-1b production
by LP cells was abolished (Figure 4K). The small residual
amounts of TNF-a may derive from neutrophils as indicated by
the fact that these cells were normally recruited in the intestine
of Ccr1/ mice (Figure S4D) and produced small amounts of
TNF-awhen purified on day 7 (Figure S3E). As already described
in Ccr1/ mice (Khan et al., 2001), intestinal lesions were less
severe on day 7 p.i. than in WT mice (Figure 4L) but the mice
died, probably because of 20- to 100-fold higher parasitic
loads in MLN, spleen, and liver than WT mice (Figures
S4E–S4G). Altogether these results indicated that the intestinal
recruitment of Ly6ChiF4/80+ inflammatory monocytes during
T. gondii-induced ileitis requires CCR1 and can be stimulated
via CCL3.
IL-15-Dependent NKp46+NK1.1+CD127– Cells Are an
Early and Major Source of CCL3 during T. gondii-
Induced Ileitis
CCL3 can be produced by cells of hematopoietic or epithelial
origin. CCL3 transcripts increased 100- to 200-fold more in LP
cells than in enterocytes of infected mice (Figure 5A). Analysis
of LP subsets sorted on day 7 p.i. indicated that CCL3 mRNA
was strongly upregulated in a subset of CD3NKp46+NK1.1+
cells (Figure 5B). In these cells, upregulation of CCL3 RNA could
already be detected at day 3 p.i., which is prior to CCR1+ inflam-
matory monocyte recruitment (Figure 5C).
Murine LP contains two distinct lineages of NKp46+ innate
lymphoid cells: IL-7-dependent Rorc+NKp46+NK1.1CD127+
cells that produce IL-22 and NKp46+NK1.1+CD127 cells that
depend on IL-15 and thus resembles classical splenic NK cells
(reviewed in Colonna, 2009; Spits and Di Santo, 2011). Consis-
tent with the hypothesis that LP NKp46+NK1.1+CD127 cells
were the IL-15-dependent source of CCL3, their absolute
number was significantly decreased in naive and infected
Il15/ mice compared to WT mice (Figure 5D) whereas the
numbers of NKp46+NK1.1CD127+ and of IL-22-containing
NKp46+ cells were unchanged (Figures S5A and S5B). This
hypothesis was confirmed by two complementary sets of exper-
iments. First, by using hematopoietic chimeras, we observed
that differentiation and/or homeostasis of LP CD3NKp46+
NK1.1+ cells required a stromal but not a hematopoietic source
of IL-15 (Figures 5E and 5F). CCL3 mRNA, recruitment of LP
Ly6ChiF4/80+ inflammatory monocytes, and ileitis severity were
significantly reduced in irradiated Il15/ mice reconstitutedwith WT bone marrow cells that lacked LP CD3NKp46+NK1.1+
cells but not in irradiated WT reconstituted with Il15/ bone
marrow, which had normal percentages of LP CD3NKp46+
NK1.1+ cells (Figures 5G, 5H, and 1E). Second, treatment of
mice with a depleting NK.1.1 antibody efficiently depleted LP
NKp46+NK1.1+CD127 cells (Figures S5C and S5D) and simul-
taneously reduced CCL3 production by LP cells (Figure 5I).
The percentage of LP Ly6ChiF4/80+ inflammatory monocytes
and IL-1b and TNF-a mRNA were significantly decreased at
day 7 p.i. and epithelial damage was attenuated (Figures
5J–5L). Altogether these data indicate that LP NKp46+NK1.1+
CD127 cells depend on a stromal source of IL-15 for their differ-
entiation and/or homeostasis and are an important source of
CCL3 during T. gondii infection that contributes to CCR1+ inflam-
matory monocyte recruitment. SomeCCL3 transcripts were also
observed in inflammatory monocytes and neutrophils (Fig-
ure S5E). A major contribution of neutrophil-derived CCL3 for
CCR1+ inflammatory monocytes recruitment seemed unlikely
because these cells were observed only late in infection and
were unaltered in the absence of IL-15 (Figure S5F). Moreover,
their efficient depletion by Ly6G antibody did not reduce CCL3
production or CCR1+ inflammatory monocyte recruitment
(Figures S5G–S5I). However, it remains possible that CCR1+
inflammatory monocyte-derived CCL3 observed late in infection
might amplify their recruitment.
CCL3 Production by CD3–NKp46+NK1.1+ Cells Is
Stimulated by IL-18
In keeping with previous observations (Dorner et al., 2004; Feh-
niger et al., 1999), we found that CCL3 was induced in purified
murine spleen NKp46+ cells by IL-15 and IL-18 and to a lesser
extent by a-IFN but not by IFN-g, IL-12, IL-21, or IL-23, nor by
STAg that may stimulate NK cells (Figure 6A; Sher et al., 1993).
A transient increase IL-15 mRNA was detected during the first
3 days p.i. in enterocytes and on day 2 in LP CD11c+ DCs
(Figures S1E and S1F). IL-15 protein was not detected, perhaps
because of its known binding to IL-15Ra that confines its expres-
sion to the surface of producing cells and/or hampers detection
(Stonier and Schluns, 2010). No increase in IL-18 mRNA was
observed but conspicuous amounts of mature IL-18 protein
were detected on days 3 and thereafter in both WT and Il15/
mice, which probably derived from enterocytes as indicated by
the fact that it was detected in the supernatants of intestinal
biopsies but not of LP cells (Figure 6B and not shown). Conse-
quently, we assessed the roles for IL-15 and IL-18 in activating
CCL3 production by NK cells by using a short treatment with
neutralizing antibody. CCL3 production and recruitment of
inflammatory monocytes were modestly but not significantly
reduced by IL-15 antibody (Figures 6C–6E) whereas IL-18 anti-
body treatment significantly reduced both parameters (Figures
6F and 6G). These results indicate that IL-18 promotes induction
of CCL3 in vivo during T. gondii infection. In contrast, IL-15 plays
a critical role in the homeostasis of intestinal NK cells, which are
the main CCL3 producers, whereas its role in CCL3 upregulation
is less clear. Contrasting with lesser inflammatory monocytes
recruitment, histology was not improved but rather impaired in
anti-IL-18-treated mice (data not shown), a paradoxical result
probably explained by the protective role of IL-18 against epithe-
lial damage (Elinav et al., 2011). IL-18 was significantly lessImmunity 37, 108–121, July 27, 2012 ª2012 Elsevier Inc. 113
Figure 4. IL-15 Promotes CCR1-CCL3-Dependent Recruitment of Inflammatory Monocytes during T. gondii-Induced Ileitis
(A, B, and H) qRT-PCR quantification of CCL2-5 transcripts (A, B) or CCR1 and CCR5 transcripts (H) in LPL from Il15/ andWTmice either naive or on indicated
p.i. days.
(C) Spontaneous secretion of CCL3 in 72 hr supernatants of LP from Il15/ and WT mice either naive or on day 7 p.i.
(D–F) Percentage of LP Ly6ChiF4/80+CCR1+ inflammatory monocytes (D), spontaneous secretion of TNF-a (E), and representative jejunal sections (F) on day 7 p.i.
in Il15/ and WT mice treated or not with CCL3 mAb.
(G) Survival curves of WT mice treated with CCL3 mAb or control isotype.
(I and J) Percentage of LP Ly6ChiF4/80+CCR1+ inflammatory monocytes (I) and of CD45+ LP cells stained with TNF-a mAb (J) on day 7 p.i. in Il15/, WT, and
Ccr1/ mice.
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NK Cell-Dependent Recruitment of Gut Monocytesproduced at late time points during infection in Il15/ compared
to WT mice (Figure 6B), probably as a consequence of lesser
epithelial damage. However, a direct role for IL-15 in regulating
epithelial IL-18 production cannot be excluded.
CCL3 and CCR1 Expression Are Upregulated in Crohn’s
Disease
In Crohn’s disease, TNF-a-producing inflammatory monocytes
play a central role in gut inflammation as attested by the effi-
ciency of therapeutic administration of TNF-a antibodies. Recent
work has identified their CD33+CD14+ phenotype and shown
their expression of several chemokine receptors, including
CCR1, which is absent on gut-resident CD33+CD14 myeloid
cells (Kamada et al., 2008). In keeping with these data, IL-1b,
TNF-a, and CCR1 mRNA were significantly upregulated in in-
flamed biopsies from Crohn’s disease patients (Figures 7A and
7B). CCL3 (but not CCL5) mRNAwas also significantly increased
in the same biopsies (Figure 7C) and there was a positive corre-
lation between CCL3 and CCR1 (spearman coefficient r: 0.64)
but not of CCL3 and CCR5mRNA (Figure 7D). Confirming recent
work (Takayama et al., 2010), NKp46+CD56+CD127CD122+ NK
cells were present in the intestine of Crohn’s disease patients
and their proportion was increased in inflamed compared to
unaffected mucosa (Figures 7E and S6). IL-15 and IL-18, known
to be upregulated in the intestine of CD patients (Liu et al., 2000;
Monteleone et al., 1999b; Pizarro et al., 1999), could synergize
and stimulate CCL3 production in CD45+CD3NKp46+CD56+
cells derived either from control blood or from the mucosa of
Crohn’s disease patients (Figures 7F and 7G). Interestingly,
CCL3 production was more readily induced by IL-15 and/or
IL-15 and IL-18 in NK cells from inflamed than from unaffected
CD mucosa (Figure 7G). Therefore, in Crohn’s disease, IL-15
and IL-18 might cooperate to promote the production of CCL3
by gut NK cells and enhance the recruitment of CCR1+ inflamma-
torymonocytes. Overall, our data highlight how IL-15-dependent
gut innate lymphoid cells might integrate local signals and tune
the intensity of intestinal inflammation by influencing the recruit-
ment of inflammatory monocytes.
DISCUSSION
In response to oral infection by the virulent 76K strain of T. gondii,
C57BL/6 mice develop an immune response, which is a two-
edged sword because it permits early control of parasite replica-
tion but results in uncontrolled intestinal inflammation lethal
within 10 days (Liesenfeld et al., 1996; Mennechet et al., 2002).
The role of IL-15 in the immune response against T. gondii infec-
tion is controversial. Combe et al. (2006) have suggested that
intestinal inflammation is reduced and T. gondii infection less
well controlled in orally infected Il15/mice. In contrast, Lieber-
man et al. (2004) did not detect any increase in cyst burden in
Il15/ mice after intraperitoneal infection. Our results confirm
that intestinal inflammation is markedly attenuated in infected(K) Spontaneous secretion of IL-1b and TNF-a by LP in WT and Ccr1/ mice ei
(L) Representative jejunal sections on day 7 in WT and Ccr1/ mice.
(M) Parasitic loads in MLN and spleen of WT and Ccr1/ mice.
NS, not significant; *p < 0.05; **p < 0.005; ***p < 0.0005. See also Figure S4.Il15/ mice. Yet, no difference could be demonstrated in para-
sitic load in intestine, liver, and spleen between Il15/ and WT
mice, suggesting that in our conditions of infection, IL-15 did
not impair early parasite control and therefore this model
was valuable to analyze the mechanisms underlying the role of
IL-15 in intestinal inflammation.
Previous work has suggested that IL-15 can promote a cyto-
lytic attack of the gut epithelium by IELs. Our data indicate that
gdTCR+ and CD8+abTCR+ IELs do not play a determinant role
in ileitis severity. This conclusion is consistent with two previous
studies (Denkers et al., 1997; Liesenfeld et al., 1996) but is
at odds with a recent report suggesting the contribution of
CCR2-dependent CD103+CD11c+ IELs to T. gondii-induced
gut inflammation (Egan et al., 2009). Yet, it is noticeable that
during T. gondii infection, CCR2 may be involved not only in
the recruitment of IELs but also in themigration of CCR1+ inflam-
matory monocytes which, as discussed below, play a central
role in T. gondii-induced ileitis.
An alternative hypothesis is a role of IL-15 in the amplification
of the T. gondii-specific Th1 cell response (Combe et al., 2006).
Based on the analysis of MLN at day 10 postinfection, Combe
et al. (2006) suggested that IL-15 is necessary for optimal
priming of Th1 cell responses. Day 10, however, is late to eval-
uate priming because parasite-loaded dendritic cells are first de-
tected in MLN on day 3 (Courret et al., 2006) and ileitis is full
blown by day 7. Furthermore, another report observes normal
serum response in Il15/ mice after intraperitoneal infection
(Lieberman et al., 2004). Herein, comparable amounts of IFN-g
were secreted by LP cells of WT and Il15/ mice on day 7 p.i.,
pleading against a major enhancing effect of IL-15 on the Th1
cell response in our conditions of infection. Yet appearance of
IFN-g transcripts was slightly delayed in MLN of Il15/ mice
and, at day 5 p.i., STAg could stimulate a minor production of
IFN-g in LPL of WT but not of Il15/mice. Whether these subtle
early differences participate in the enhancing effect of IL-15 on
inflammation remains unclear.
Contrasting with the comparable production of IFN-g in the
intestinal mucosa at day 7 in both animal groups, secretion of
IL-1b, TNF-a, and IL-6 was significantly diminished in Il15/
mice. The cytokines were mainly produced by Ly6ChiF4/
80+Ly6GCD11b+CD11cCCR1+ inflammatory monocytes.
In vitro studies have suggested that IL-15 enhances the
secretion of TNF-a by human monocytes via a T cell contact-
dependent mechanism (Liu et al., 2000; McInnes et al., 1996).
Yet, adding IL-15 alone or in combination with other stimuli to
in vitro culture of peritoneal or LP cells failed to enhance TNF-a
and IL-1b secretion, arguing against a role of IL-15 in inflamma-
tory monocyte differentiation. In contrast, IL-15 was necessary
for maximal in vivo recruitment of CCR1+ inflammatory mono-
cytes, as shown by the fact that their numbers increased
significantly less in the LP of Il15/ than of WT infected mice.
Mechanisms controlling inflammatory monocytes migration
into the inflamed gut are not fully delineated. Previous workther naive or on day 7 p.i. (ND, not detectable).
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Figure 5. CCL3 Production during T. gondii-Induced Ileitis Depends on Intestinal IL-15-Dependent NKP46+NK1.1+CD127– Cells
(A–C) qRT-PCR quantification of CCL3 transcripts in enterocytes and LP cells (A), in flow cytometry-sorted CD45+ LP B (CD19+), NK (NK1.1+), and T (CD3+) cells
(B), and in flow cytometry-sorted Ly6ChiF4/80+CCR1+ inflammatory monocytes or CD3NKp46+NK1.1+ LP cells at indicated days in WT mice (C) (each point
represents a pool of ten mice).
(D) Absolute numbers of NKP46+NK1.1+CD3 cells in naive and infected WT and Il15/ mice.
(E) Comparison by flow cytometry of CD3NK1.1+ and CD3+NK1.1+ cells in LP 2 months after reconstitution of irradiated Il15/ mice with WT bone marrow
(Il15/ + BM WT) or irradiated mice WT with Il15/ (WT + BM Il15/) or WT bone marrow (WT + BM WT) compared to unmodified Il15/ mice. One repre-
sentative out of six experiments.
(F) Flow cytometry determination of LP CD3NKp46+NK1.1+ cells in hematopoietic chimera on day 7 p.i.
(G) qRT-PCR quantification of CCL3 transcripts in jejunum of hematopoietic chimeras on day 7 p.i.
(H and J) Flow cytometry determination of Ly6ChiF4/80+ LP CCR1+ inflammatory monocytes on day 7 p.i. in hematopoietic chimeras (H) or in mice treated with
NK1.1 antibody (J).
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Figure 6. CCL3 Production by CD3–NKp46+NK1.1+ Cells Is Stimulated by IL-15 and IL-18
(A) ELISA dosage of CCL3 in 72 hr supernatants of flow cytometry-sorted spleen CD3NKp46+NK1.1+ cells isolated from naive WT mice and stimulated with
indicated cytokines.
(B) ELISA dosage of IL-18 in 24 hr supernatants of jejunal biopsies from Il15/ and WT mice at indicated p.i. days.
(C–H) ELISA dosage of CCL3 (C, F) and TNF-a (E, H) in 72 hr supernatants of LP cells from WT mice treated or not with IL-15 (C–E) or IL-18 (F–H) antibodies.
(D and G) Flow cytometry determination of LP Ly6ChiF4/80+CCR1+ inflammatory monocytes on day 7 p.i. in antibody-treated mice.
NS, not significant; *p < 0.05; **p < 0.005; ***p < 0.0005.
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NK Cell-Dependent Recruitment of Gut Monocytesshowed that inflammatory monocytes are not recruited in
the intestine of T. gondii-infected Ccr2/ mice (Dunay et al.,
2008). Yet, CCR2 was dispensable for inflammatory monocyte
migration into the inflamed gut and instead controlled monocyte
emigration from bone marrow (Dunay et al., 2008). Herein, the
lesser amounts of CCR1 and CCL3 mRNA in the intestine of in-
fected Il15/ than in that of WT mice pointed to their possible
role in the local recruitment of inflammatory monocytes. Dem-
onstrating the instrumental role of CCR1, LP Ly6ChiF4/80+
Ly6GCD11b+CD11c inflammatory monocytes were almost
undetectable in infected Ccr1/ mice, a result that contrasted
with the normal recruitment of neutrophils. Consistent with
previous observations in Ccr1/ mice (Khan et al., 2001) and(I) ELISA dosage of CCL3 in 72 hr supernatants of LP cells isolated on day 7 p.i.
(K) qRT-PCR quantification of IL-1b and TNF-a transcripts in LP cells from anti-N
(L) Representative jejunal sections of WT mice treated or not with anti-NK1.1 on
NS, not significant; *p < 0.05; **p < 0.005; ***p < 0.0005. See also Figure S5.with the hypothesis that CCR1+ inflammatory monocytes partic-
ipate in tissue damage, histology was improved in Ccr1/mice.
Yet, and as also observed by Khan et al. (2001), the parasitic load
was markedly increased in spleen and liver, leading to the rapid
death of infected animals. The latter finding confirms the
important role of inflammatory monocytes in parasite control
described in Ccr2/ mice (Dunay et al., 2008). The extensive
parasite replication observed in the intestine of Ccr2/ mice
was, however, not observed in Ccr1/ mice, perhaps because
of difference in strains and/or conditions of infection. Therefore,
similar to CD4+ Th1 cells, CCR1+ inflammatory monocytes
probably can serve a dual role in T. gondii infection and partici-
pate in both tissue damage and parasite control. CCR1 wasfrom anti-NK1.1-treated mice.
K1.1-treated mice.
day 7.
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Figure 7. CCL3 and CCR1 Are Increased in Crohn’s Disease
(A–C) qRT-PCR quantification of IL-1b, TNF-a (A), CCR1, CCR5 (B), CCL3, CCL5 (C), transcripts in intestinal biopsies from controls (n = 15) and from Crohn’s
disease patients (n = 19).
(D) Correlation between CCL3 and CCR1 transcripts (r = 0.76, p = 0.0002) and CCL3 and CCR5 transcripts (r = 0.35, p = 0.1366).
(E) Flow cytometry analysis showing an increase in CD3NKp46+CD56+NKp44CD122+CD127 cells in inflamed (CCR1+ inflamed mucosa) compared to
unaffected (UM) mucosa from the same CD patient (one representative out of four experiments).
(F) Percentage of CCL3 producing peripheral CD3NKP46+CD56+ human NK cells after stimulation with 20 ng/ml IL-15 and/or IL-18 prior to or not 24 hr
incubation with 20 ng/ml IL-15 (n = 3).
(G) Percentage of CCL3 producing CD3NKP46+CD56+ cells in unaffected (left) or inflamed (right) CD mucosa after the same stimulation as in (F) (one out of two
experiments).
NS, not significant; *p < 0.05; **p < 0.005; ***p < 0.0005. See also Figure S6.
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NK Cell-Dependent Recruitment of Gut Monocytesshown to play a prominent role for inflammatory monocyte
migration into inflamed joints (Schall and Proudfoot, 2011). Our
results provide evidence of a comparable role for CCR1 in the
inflamed gut.118 Immunity 37, 108–121, July 27, 2012 ª2012 Elsevier Inc.CCR1 has two main ligands, CCL3 and CCL5. Both chemo-
kines were massively upregulated in the intestine of WT infected
by T. gondii but only CCL3 was significantly less produced in
Il15/ mice, pointing to an IL-15-dependent source of CCL3.
Immunity
NK Cell-Dependent Recruitment of Gut MonocytesTreatment of infected WT mice by a blocking CCL3 antibody
decreased inflammatory monocytes recruitment, confirming
a role for this chemokine. Reduction of inflammatory monocytes,
however, was less drastic than in Ccr1/ mice, either because
of the complementary contribution of CCL5 and/or because of
incomplete blockade by the antibody.
During T. gondii infection, CCL3 was first upregulated in LP
NKp46+NK1.1+CD127 NK cells and our results indicate that
the latter cells were the source of CCL3 regulated by IL-15. Con-
firming and extending previous results (Satoh-Takayama et al.,
2010), we observed that homeostasis of gut NK1.1+ NK cells
depends on a stromal source of IL-15 that is presumably epithe-
lial cells. Moreover, treatment with a depleting NK1.1 antibody
reduced CCL3 production, inflammatory monocyte recruitment,
and ileitis severity. The latter result is in keeping with a previous
study showing that NK depletion via the asialoGM1 antibody
markedly reduced intestinal inflammation during T. gondii infec-
tion although the mechanism was not elucidated (Khan et al.,
2006). Our results indicate that NK-derived CCL3 controls
inflammatory monocyte recruitment. NK cells produced CCL3
before and during inflammatory monocyte recruitment. At late
time points, neutrophils and inflammatory monocytes became
a complementary source of CCL3. CCL3 production by inflam-
matory monocytes may perhaps auto-amplify their recruitment
but a major role of neutrophils was excluded because their
depletion did not reduce the production of CCL3 or inflammatory
monocyte recruitment.
In vitro analysis of the cytokines able to trigger CCL3 in murine
NK cells suggested a role for IL-15 and/or IL-18. During T. gondii
infection, an early and transient increase in IL-15 mRNA was
documented whereas IL-18 secretion, probably derived from
epithelial cells, was strongly induced later during infection.
Neutralization of IL-15 or IL-18 in vivo by a transient antibody
treatment demonstrated a role for IL-18 in CCL3 induction and
inflammatory monocyte recruitment, although the role for
IL-15 in this process was less clear. Surprisingly, blocking
IL-18 did not improve but rather exacerbated intestinal lesions,
consistent with recent evidence that epithelium-derived IL-18
serves a key protective role against intestinal epithelial damage
(Elinav et al., 2011). In T. gondii ileitis, IL-18 may thus simulta-
neously promote the recruitment of inflammatory monocytes
and protect against epithelial damage. Altogether, our results
indicate that IL-15 controls the homeostasis of CCL3-producing
intestinal NK cells whereas IL-18 induces CCL3 synthesis during
T. gondii ileitis. Other complementary mechanisms may operate
to stimulate CCL3 expression during T. gondii infection,
including upregulation of IFN-a (Foureau et al., 2010) or induced
ligands that may engage activating NK receptors (Ortaldo et al.,
2001).
T. gondii-induced ileitis is one rare mouse model of acute
inflammation affecting selectively the ileum and, as such, can
be viewed as a possible model for Crohn’s disease. Strikingly,
TNF-a-producing inflammatory monocytes also play a central
role and both IL-15 and IL-18 are upregulated in Crohn’s
disease-inflamed intestine (Liu et al., 2000; Monteleone et al.,
1999a; Pizarro et al., 1999). Furthermore, it has recently been
suggested that serum detection of IL-15 in Crohn’s disease
patients can predict their response to TNF-a antibodies (Bou-
chaud et al., 2010). Confirming previous work (Takayama et al.,2010), substantial numbers of LP NKp46+CD56+CD127 NK
cells were present in the intestine of Crohn’s disease patients.
Moreover, IL-15 and IL-18 exerted synergistic effects on the
production of CCL3 by peripheral and intestinal NK cells, a result
in keeping with the induction of IL-18R by IL-15 on human
NK cells (Fehniger et al., 1999). Finally there was a positive
correlation between the amounts of CCL3 and CCR1 mRNA in
intestinal biopsies from Crohn’s disease patients. It is therefore
tempting to hypothesize that in Crohn’s disease patients as
well as in mice infected by T. gondii, intestinal NKp46+CD56+
NK cells might produce CCL3 and thereby recruit TNF-a-
producing CCR1+ inflammatory monocytes and enhance
intestinal inflammation. Future work, however, is necessary to
confirm this hypothesis and determine whether CCL3 or (more
probably) CCR1 are meaningful therapeutic targets in Crohn’s
disease.
Recent work has enlightened the role of a spectrum of intes-
tinal innate lymphoid cells in the early response to pathogens
and/or intestinal inflammatory responses. A particular emphasis
has been put on the subset that expresses NKp46+ in mice and
NKp44+ in humans and produces IL-22, a cytokine important
in the defense against bacteria (Colonna, 2009; Spits and Di
Santo, 2011). Our results indicate that a distinct subset of IL-
15-dependent gut NKp46+ cells may be activated during the
response to intracellular pathogens and can, via CCL3, partici-
pate in the recruitment of CCR1+ inflammatory monocytes. IL-
15-dependent NKp46+ cells may thereby participate in gut




8- to 12-week-old inbred male C57BL/6, Il15/, Prf1/, B2m/, Ifng/,
Tcrd/, and Ccr1/ mice (provided by P. Murphy and J.L. Gao, NIAID,
NIH, Bethesda, MD) were raised under specific-pathogen-free conditions in
animal facilities of Institut Pasteur according to European guidelines. To
produce hematopoietic chimeras, WT (CD45.1) or Il15/ (CD45.2) recipient
mice were lethally irradiated at 900 rads with a Ce137 source and intravenously
injected with 5 3 106 BM cells from either WT or Il15/ donor mice. After
8 weeks, reconstitution was controlled with CD45.2 and CD45.1 markers on
blood lymphocytes. For infection, mice were intragastrically gavaged with 35
cysts from T. gondii 76K strain and their weight and survival were monitored.
Histology was evaluated on paraffin sections and parasitic load determined by
quantitative PCR on day 7 p.i. (Reischl et al., 2003). For in vivo blocking or
depletion experiments, WT mice received intraperitoneal injections of 100 mg
of control isotypes or of CCL3 mAb (MAB450, IgG2a, R&D Systems) on
days 1 and 2 p.i.; NK1.1 mAb (clone PK136, IgG2a, AbDserotec) on days 1
and +1; IL-18 rabbit-anti-mouse antibody (Acris) on days 1 and 2; and 50 mg
of murine IL-15 mAb (clone M96, IgG1, gift from E. Butz, AMGEN) on days
3 and 4.
Controls and Patients
Peripheral blood was obtained from healthy adult volunteers. Endoscopic ileal
biopsies from 19 patients with Crohn’s disease and from 15 individuals under-
going a diagnostic procedure but with normal histology were obtained from
patients (age 7–15 years) according to protocol AOM08087 approved by
Ethical Committee Ile de France II. Ileal resection samples were from four
additional Crohn’s disease patients undergoing therapeutic surgery.
Lymphocyte Isolation and Cell Cultures
Mouse lymphocytes were isolated from blood, spleen, MLN, small intestinal
epithelium, and LP as described (Mennechet et al., 2004). PeritonealImmunity 37, 108–121, July 27, 2012 ª2012 Elsevier Inc. 119
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NK Cell-Dependent Recruitment of Gut Monocytesmononuclear cells were harvested in cold PBS. Human PBL were isolated on
Ficoll Hypaque gradient.
All cultures were performed in RPMI supplemented with 10% fetal calf
serum (FCS), 100 U/ml penicillin, 100 mg/ml streptomycin, 30 mM HEPES
(GIBCO), and 0.05 mM b-mercaptoethanol (Biorad) at 37C and in 5% CO2.
Intestinal biopsies (5 mm) were cultured alone for 24 hr in 48-well plates.
Lymphocytes and peritoneal mononuclear cells (1 3 106/ml) were cultured
in 96-well plates alone or in the presence of human IL-15 (R&D Systems) or
of 10 mg/mL STAg (Grunvald et al., 1996). Production of IL-1b, IL-6, TNF-a,
IFN-g, or CCL3 was measured in culture supernatants by ELISA (R&D
Systems). CCL3 secretion was induced with murine cytokines (R&D Systems)
for mouse cells as indicated in Figure 6 or with human IL-15 and/or IL-18 (R&D
Systems) for human cells.
Phenotyping and Lymphocyte Subset Isolation by Flow Cytometry
Isolated cells were incubated with Fc block (2.4G2, BD PharMingen) for 10min
and then stained with various mixes of directly coupled mAbs: Ly6C-FITC,
Ly6G-PE, F4/80-PECy5, CD3-PE, CD3-APCCy7, NK1.1-APC, CD127-
PECy7, NKP46-PECY5, CD11b-APCH7, CD11c-PECY7, abTCR-APC (BD
PharMingen), F4/80 PeCy5.5, CD45-eFluor450 (eBiosciences), Aqua view
blue (Invitrogen), or control isotypes. For intracellular staining, LPL suspen-
sions were incubated for 4 hr in culture medium added with 2 ml/ml Brefeldin
A (Sigma-Aldrich) at 37C. After surface staining, cells were fixed with 2%
paraformaldhehyde (Euromedex), permeabilized with 0.5% saponin (Sigma),
and stained intracellularly with IFN-g-APC, TNF-a-APC (BD PharMingen),
IL-22-PE (eBioscience) (murine cells), or CCL3-PE (human cells) mAbs (R&D
systems). Cells were analyzed on a FACSCanto II or sorted with a FACSAria
cell sorter II (BD Biosciences).
Quantitation of Gene Expression by Real-Time PCR
Tissueswere harvested in RNA later and disrupted in RLT buffer (QIAGEN) with
a FastPrep machine (MP Biomedicals). Cells were lysed in RLT buffer. RNA
was extracted with RNAeasy kit (QIAGEN) and 1 mg was reversed transcribed
to cDNA with Superscript II Reverse Transcriptase (Invitrogen). qRT-PCR was
performed with TaqMan gene expression assays HPRT, IFN-g, IL-1b, TNF-a,
IL-6, CCL3-5, CCR1, CCR2, CCR5, and TaqMan Universal PCR master mix
and GeneAmp 7000 machine (Applied Biosystems). cDNA samples were
assayed in duplicates and expression was normalized relative to HPRT with
Ct calculation.
Statistical Analysis
Groups were compared with GraphPad Prism software by unpaired Mann-
Whitney test except for survivals, which were compared with Log-rank
(Mantel-Cox) test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/
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